Skip to content
10-Q

Quarterly Report

EIDOS THERAPEUTICS, INC.

0001564590-20-023604

← back to feed
Filed
May 8, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · May 5, 2020 38.54M sh
Shares Diluted Q1 2020 · Mar 31, 2020 38.33M sh
Shares Diluted Q1 2020 · Mar 31, 2019 36.77M sh
Capex Q1 2020 · Mar 31, 2020 $51K
Operating Cash Flow Q1 2020 · Mar 31, 2020 −$18.88M
Operating Cash Flow Q1 2020 · Mar 31, 2019 −$10.11M
Long Term Debt Q1 2020 · Mar 31, 2020 $16.32M
Long Term Debt Q1 2020 · Dec 31, 2019 $16.11M
Cash And Equivalents Q1 2020 · Mar 31, 2020 $196.52M
Cash And Equivalents Q1 2020 · Dec 31, 2019 $191.16M
Cash And Equivalents Q1 2020 · Mar 31, 2019 $147.06M
Cash And Equivalents Q1 2020 · Dec 31, 2018 $157.15M
Stockholders Equity Q1 2020 · Mar 31, 2020 $174.85M
Stockholders Equity Q1 2020 · Dec 31, 2019 $171.43M
Stockholders Equity Q1 2020 · Mar 31, 2019 $144.3M
Stockholders Equity Q1 2020 · Dec 31, 2018 $155.01M
Current Liabilities Q1 2020 · Mar 31, 2020 $11.82M
Current Liabilities Q1 2020 · Dec 31, 2019 $10.43M
Total Liabilities Q1 2020 · Mar 31, 2020 $33.75M
Total Liabilities Q1 2020 · Dec 31, 2019 $32.39M
Current Assets Q1 2020 · Mar 31, 2020 $200.59M
Current Assets Q1 2020 · Dec 31, 2019 $195.92M
Total Assets Q1 2020 · Mar 31, 2020 $208.6M
Total Assets Q1 2020 · Dec 31, 2019 $203.82M
Sga Expense Q1 2020 · Mar 31, 2020 $5.31M
Sga Expense Q1 2020 · Mar 31, 2019 $4.04M
Rd Expense Q1 2020 · Mar 31, 2020 $17.58M
Rd Expense Q1 2020 · Mar 31, 2019 $8.55M
Net Income Q1 2020 · Mar 31, 2020 −$22.82M
Net Income Q1 2020 · Mar 31, 2019 −$11.73M
Operating Income Q1 2020 · Mar 31, 2020 −$22.89M
Operating Income Q1 2020 · Mar 31, 2019 −$12.58M